Heidelberg Pharma AG Capital Reinvestment Ratio

Latest as of May 2022: 0.00x

Heidelberg Pharma AG capital reinvestment ratio. Heidelberg Pharma AG (HPHA) has a Capital Reinvestment Ratio of 0.00x as of May 2022, meaning it reinvests 0% of its operating cash flow (€13.59 Million) in capital expenditures (€50.81K). Check total reinvestment intensity of Heidelberg Pharma AG to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

€13.59 Million

EUR

Capital Expenditures

€50.81K

EUR

Data as of

May 2022

Most recent filing

Heidelberg Pharma AG Capital Reinvestment Ratio by Year (None–None)

Heidelberg Pharma AG capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see HPHA cash flow conversion.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow